Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2020

View Archived Issues

Circulating miR-638 and miR-521: potential screening biomarkers for cervical squamous cell carcinoma

Acid test for therapeutic peptides

Mersana begins phase I study of XMT-1592 in NSCLC and ovarian cancer

Interim phase I data presented for mRNA-1273 coronavirus vaccine

Cellect's ApoGraft to be studied for treatment of COVID-19-related pulmonary diseases

Namodenoson reduces liver fat and fibrosis in phase II NAFLD study

FDA clears IND application for phase II study of merimepodib in advanced COVID-19

LATS2 and KIBRA are prognostic markers in patients with ccRCC

Intermediary results presented for VLP COVID-19 vaccine in mice

Heron Therapeutics initiates phase Ib/II study of HTX-034 for postoperative pain

Human L-opsin gene therapy shows potential for treating blue cone monochromacy

Incyte presents novel PI3K-gamma inhibitors

Janssen discovers novel potent EP inhibitors

ELX-01 shows functional activity in a model of nonsense mutation-related IRD

Metacrine patents new AOC3 inhibitors

Arrien Pharmaceuticals synthesizes MELK and/or FLT3 inhibitors

Bristol-Myers Squibb presents new Toll-like receptor antagonists

New adjuvant reverses MDR in Gram-negatives

New ATR kinase inhibitors identified by Repare Therapeutics

Maxinovel Pharmaceuticals patents PD-1/PD-L1 interaction inhibitors

FDA approves Tecentriq for first-line metastatic NSCLC with high PD-L1 expression

Sorrento's STI-1499 demonstrates 100% inhibition of SARS-CoV-2 virus infection in vivo

European Commission grants conditional approval for Zolgensma for SMA

Phase IIb study of Liproca Depot in prostate cancer meets endpoints

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...